Clinical Trial Update: Drug-drug Interaction Between Simvastatin and SHR3824 [Phase 1]

View source ↗

Summary

Clinical trial update describing a potential drug-drug interaction between simvastatin and SHR3824 in a Phase 1 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SHR3824
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 1 | Status: UNKNOWN